Zobrazeno 1 - 4
of 4
pro vyhledávání: '"John Storring"'
Autor:
Rena Buckstein, Lisa Chodirker, Karen W.L. Yee, Michelle Geddes, Heather A. Leitch, Grace Christou, Versha Banerji, Brian Leber, Dina Khalaf, Eve St-Hilaire, Nicholas Finn, Thomas Nevill, Mary-Margaret Keating, John Storring, Anne Parmentier, Aksharh Thambipillai, Derek Tang, Christopher Westcott, Chris Cameron, Paul Spin
Publikováno v:
Leukemialymphoma.
Many patients with lower-risk myelodysplastic syndromes (LR MDS) require long-term red blood cell (RBC) transfusions to manage anemia. The consequences of RBC transfusions in LR MDS with ring sideroblasts (LR MDS-RS) are not well known. We estimated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ec842fa7b23e48363ede6bc64fea2b0
https://pubmed.ncbi.nlm.nih.gov/36606533
https://pubmed.ncbi.nlm.nih.gov/36606533
Autor:
Rena Buckstein, Lisa Chodirker, Lee Mozessohn, Karen W.L Yee, Michelle Geddes, Nancy Zhu, April Shamy, Heather A. Leitch, Grace Christou, Versha Banerji, Leber Brian, Dina Khalaf, Eve St-Hilaire, Nicholas Finn, Thomas Nevill, Mary-Margaret Keating, John Storring, Robert Delage, Anne Parmentier, Aksharh Thambipillai, Mohammed Siddiqui, Christopher Westcott, Chris Cameron, Alexandre Mamedov, Paul Spin, Derek Tang
Publikováno v:
Leukemialymphoma. 63(13)
Patients with lower-risk (LR) myelodysplastic syndromes (MDS) with ring sideroblasts (RS) have better prognosis than those without RS, but how they fare over time is not fully understood. This study's objective was to assess the natural history of LR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::173f6ad68c620b49783bcf18e8283323
https://pubmed.ncbi.nlm.nih.gov/36095125
https://pubmed.ncbi.nlm.nih.gov/36095125
Autor:
Michael Wang, Wojciech Jurczak, Mats Jerkeman, Judith Trotman, Pier Luigi Zinzani, Jan Andrzej Walewski, Jun Zhu, Stephen Spurgeon, Andre Goy, Paul A. Hamlin, David Belada, Muhit Ozcan, John Storring, David John Lewis, Jose Angel Hernandez Rivas, Todd Henninger, Sanjay Deshpande, Rui Qin, Steven Le Gouill, Martin H. Dreyling
Publikováno v:
Journal of Clinical Oncology. 40:LBA7502-LBA7502
LBA7502 Background: Elderly patients (pts) with MCL are unsuitable for intensive chemotherapy or transplantation due to excessive toxicities. Single-agent ibrutinib (Ibr), a first-in-class, oral Bruton’s tyrosine kinase inhibitor (BTKi), has transf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2dec34ef27774b34db3d25cefd4b0e79
https://doi.org/10.1200/jco.2022.40.17_suppl.lba7502
https://doi.org/10.1200/jco.2022.40.17_suppl.lba7502
Autor:
Matthew D. Seftel, Anna Serebrin, Pascal Lambert, Julie Bergeron, Janeve Everett, Andrea Kew, David Jones, Catherine Meloche, Kristjan Paulson, Mitchell Sabloff, Ismial Sherif, John Storring, Donna Turner
Publikováno v:
Blood. 122:1714-1714
Introduction Despite widespread use of all-trans retinoic acid (ATRA) in treatment of Acute Promyelocytic Leukemia (APL), recent studies in the US1 and Sweden2 have reported continuing high rates of early death. Patient age has appeared to be an impo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a24f524766f210d7e8695fc164bfce82
https://doi.org/10.1182/blood.v122.21.1714.1714
https://doi.org/10.1182/blood.v122.21.1714.1714